Literature DB >> 2015170

Differing calcium sensitivities of human cerebral and digital arteries, human metatarsal veins, and rat aorta.

V Iwanov1, R F Moulds.   

Abstract

1. The effects of the voltage dependent calcium channel blocking agent nifedipine, and of a calcium free bathing medium, on the responses of human blood vessels obtained postmortem to various agonists have been compared with those of the rat aorta. The human vessels studied were digital arteries, basilar arteries and metatarsal veins. 2. Responses to potassium chloride (5-80 mM), noradrenaline (10(-9)-10(-4) M), 5-hydroxytryptamine (10(-8)-10(-4) M) and U46619 (10(-11)-10(-6) M), in the presence and absence of nifedipine (1, 10, and 100 nM) or in a calcium-free bathing medium, were assessed using an area-under-curve analysis. 3. In general, the order of sensitivity of the vessels to inhibition of agonist induced contractures by nifedipine was basilar arteries greater than metatarsal veins = digital arteries = rat aorta. 4. For all the vessels, the order of sensitivity for antagonism of responses to the agonists by nifedipine was potassium chloride greater than 5-hydroxytryptamine = noradrenaline greater than U46619. 5. A calcium free bath inhibited responses of digital arteries to potassium chloride more than noradrenaline, 5-hydroxytryptamine or U46619, and responses of rat aorta to a greater extent than responses of the digital arteries. 6. In the rat aorta, a calcium-free bath inhibited responses to all agonists (except KCl) to a greater degree than did nifedipine. 7. We conclude that inhibition of extracellular calcium entry through voltage dependent calcium channels affects contractile responses of different blood vessels to different extents, and, within the same blood vessel, responses to different contractile agonists to different extents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015170      PMCID: PMC1368411          DOI: 10.1111/j.1365-2125.1991.tb03856.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Calcium requirement for activation of intact aortic smooth muscle.

Authors:  C Van Breemen
Journal:  J Physiol       Date:  1977-11       Impact factor: 5.182

Review 2.  Tissue specificity of dihydropyridine-type calcium antagonists in human isolated tissues.

Authors:  T Godfraind; N Morel; M Wibo
Journal:  Trends Pharmacol Sci       Date:  1988-01       Impact factor: 14.819

Review 3.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

Review 4.  The link between agonist action and response in smooth muscle.

Authors:  L Hurwitz; A Suria
Journal:  Annu Rev Pharmacol       Date:  1971       Impact factor: 13.820

5.  A human arterial preparation for studying the effects of vasoactive agents.

Authors:  R A Jauernig; R F Moulds
Journal:  Circ Res       Date:  1978-03       Impact factor: 17.367

6.  In vitro differences between human arteries and veins in their responses to hydralazine.

Authors:  S Lipe; R F Moulds
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

7.  Prostaglandin endoperoxides promote calcium release from a platelet membrane fraction in vitro.

Authors:  J M Gerrard; A M Butler; G Graff; S F Stoddard; J G White
Journal:  Prostaglandins Med       Date:  1978-11

8.  Relaxation of large coronary artery by verapamil, D600, and nifedipine is constrictor selective: comparison with glyceryl trinitrate.

Authors:  J A Angus; R M Brazenor
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

9.  Selective action of diltiazem on cerebral vascular smooth muscle in the rabbit: antagonism of extrinsic but not intrinsic maintained tone.

Authors:  J A Bevan
Journal:  Am J Cardiol       Date:  1982-02-18       Impact factor: 2.778

10.  Evidence for greater susceptibility of isolated dog cerebral arteries to Ca antagonists than peripheral arteries.

Authors:  K Shimizu; T Ohta; N Toda
Journal:  Stroke       Date:  1980 May-Jun       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.